SCHEMBL5203531

SCHEMBL5203531

Nc1ncc(Oc2ccc(Cl)cc2)c(NC(CO)CCO)n1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
DRD1 P21728 1/20 0.39
HTR2A P28223 1/20 0.39
ADORA1 P30542 1/20 0.39
KCNH2 Q12809 8/20 0.38
TLR8 Q9NR97 8/20 0.38
TLR7 Q9NYK1 3/20 0.38
SCN9A Q15858 2/20 0.37
SCN5A Q14524 1/20 0.37
CCNT1 O60563 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
CDK9 P50750 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1375417 0.93 SCN9A (0.40) CYP2D6KCNH2TLR8TLR7SCN9A
Hydrochloric Acid SCHEMBL5209419 0.88 KDM4E (0.43) KCNH2TLR8TLR7SCN9ASCN5A
SCHEMBL1379499 0.84 MEN1 (0.39) HTR2AKCNH2SCN9ASCN5ACCNT1
SCHEMBL5205013 0.80 KCNH2 (0.40) CYP2D6KCNH2SCN9ASCN5ACCNT1
SCHEMBL5204141 0.79 KCNH2 (0.36) KCNH2SCN9ASCN5ACCNT1CCNC
SCHEMBL5205051 0.78 SCN9A (0.38) CYP2D6KCNH2SCN9ASCN5ACCNT1
SCHEMBL1376217 0.78 NUDT1 (0.43) KCNH2SCN9ASCN5ACCNT1CCNC
SCHEMBL5204086 0.78 SCN9A (0.39) CYP2D6KCNH2SCN9ASCN5ACCNT1
SCHEMBL5205246 0.78 SCN9A (0.45) CYP2D6KCNH2SCN9ASCN5ACCNT1
SCHEMBL7512201 0.77 RXFP1 (0.50) CYP2D6KCNH2TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
EP-1165523-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES Krenitsky Pharmaceuticals, Inc. (US) 2002-01-02 EP disclosed
WO-2000061562-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC. (US) 2000-10-19 WO disclosed